Another difficult week for the markets. Here's the weekly list.
| Symbol | BB | Zacks | PEG | SuppDem | VL | IBD Stock checkup |
| ESRX | 1 | 1 | 1 | 1 | A+ | |
| LIFC | 1 | 1 | 2 | 1 | A+ | |
| FLS | 1 | 1 | 1 | 1 | A | |
| NOV | 1 | 1 | 1 | 1 | A- | |
| AMTD | 1 | 1 | 1 | A+ | ||
| BIDU | 1 | 1 | 2 | A+ | ||
| CF | 1 | 1 | 1 | A+ | ||
| DE | 1 | 1 | 1 | A+ | ||
| MATK | 1 | 1 | 1 | A+ | ||
| MOS | 1 | 1 | 1 | A+ | ||
| ORCL | 1 | 1 | 1 | A+ | ||
| POT | 1 | 1 | 1 | A+ | ||
| SWN | 1 | 2 | 1 | A+ | ||
| TNE | 1 | 1 | 1 | A+ | ||
| VIP | 1 | 1 | 1 | A+ | ||
| AAPL | 1 | 2 | 1 | A | ||
| ACO | 1 | 1 | 1 | A | ||
| AG | 1 | 1 | 1 | A | ||
| CLB | 1 | 1 | 1 | A | ||
| GOOG | 1 | 1 | 1 | A | ||
| JASO | 1 | 1 | 1 | A- | ||
| NDAQ | 1 | 1 | 1 | A- | ||
| NE | 1 | 1 | 1 | A- | ||
| NOK | 1 | 1 | 1 | A- |
Martek Biosciences is new to the core list. It sells novel products from microalgae, fungi, and other microbes (yum!). It sells a vegetarian source of the omega-3 fatty acid DHA for use as a vitamin supplement.
Core list (with n of 10 weeks passing):| Symbol | Passing weeks | Earnings |
| AAPL | 10 | |
| ESRX | 10 | |
| GOOG | 10 | |
| LIFC | 10 | |
| MOS | 10 | |
| NDAQ | 10 | |
| NOK | 10 | |
| NOV | 10 | |
| VIP | 10 | |
| FLS | 10 | |
| ISRG | 9 | |
| PCLN | 9 | |
| PCP | 9 | |
| ACO | 9 | |
| BOOM | 8 | |
| CLB | 8 | |
| CNH | 7 | |
| GME | 7 | |
| RIMM | 7 | |
| SPWR | 7 | |
| AMZN | 7 | Earn 30-Jan |
| OTEX | 7 | |
| VMI | 7 | |
| AG | 7 | |
| DE | 7 | Div 31-Jan |
| JASO | 7 | Split 8-Feb |
| BGC | 6 | |
| PSEM | 6 | |
| SLB | 6 | |
| FTI | 6 | |
| CF | 6 | |
| KCI | 5 | |
| LOGI | 5 | Earn 17-Jan |
| SXE | 5 | |
| SYNA | 5 | |
| MATK | 5 | |
The IBD is agreeing with me that the markets are in a correction. Most of the major indices are below their 200-day Simple Moving Average. While I believe the stocks on the core list to be among the best from which you can choose, their price movement is largely influenced by the movement of the market, which is dismal.
The market is waiting with bated breath to see not if, but by how much Fed chair Bernanke will cut rates. As I write, he is testifying before Congress, and the news is not good. He is urging Congress to pass a stimulus package, and quickly. (It reminds me of the medical shows when they keep on zapping the patient with a flat ECG. After the third or fourth try, one of the doctors has to "call it," that is, declare the time of death.)
In 2002, before he was nominated to the august position, he had given a speech about deflation in Japan, and how to prevent it from happening here. He also came up with a colorful analogy: If a helicopter came and dropped on each person the cash they already owned, doubling the number of dollars they had in their possession, then all prices would double the next day.
I remain skeptical that anyone would be able to reverse fiscal and monetary excess, especially the central bank that caused the latter. I will try to post a list of short candidates soon.
No comments:
Post a Comment